Even patients who developed HCC post‐treatment did not have significant variations with only two patients showing a small increase in alpha‐fetoprotein levels, but always within the normal limit, and with just one patient who presented normal values before therapy and then manifested a large increase in alpha‐fetoprotein levels following therapy (>30 × ULN). Here, AFP is linked to hepatocellular carcinoma.